Lyons P A, Allan J E, Carrello C, Shellam G R, Scalzo A A
Department of Microbiology, University of Western Australia, Nedlands, Perth.
J Gen Virol. 1996 Oct;77 ( Pt 10):2615-23. doi: 10.1099/0022-1317-77-10-2615.
The amino acid sequence YPHFMPTNL of pp89, the ie1-encoded product of murine cytomegalovirus (MCMV; Smith strain), constitutes an immunodominant T cell epitope recognized in association with H-2Ld. Nucleotide sequencing of MCMV isolates derived from wild mice identified variation between amino acids 147-192 of pp89 in 19 of 27 isolates, including the region encompassing the CTL epitope (amino acid residues 168-176). Four groups of isolates with naturally occurring variant sequences for the CTL epitope were defined: (1) YPHFMPPNL; (2) YPHFMPPSL; (3) YPHFIPPSL; and (4) YLDFMPPNL. The remaining isolates, and the laboratory strains K181 and Vancouver, showed complete identity with the Smith strain. Polyclonal pp89 (Smith strain)-specific CTL only weakly recognized target cells infected with MCMV from most variant groups. No lysis of cells infected with isolate N1 from group 4 was detected. Analyses of cross-reactive recognition of YPHFMPTNL peptide-coated targets by CTL primed with variant MCMV isolates showed that the group 2 and 3 isolates, G4 and K6, respectively, but not the group 4 isolate N1, elicited CTL that exhibited a cross-reactive response. Furthermore, while the group 2 and 3 isolates G4 and K6 were able to prime CTL responses that displayed reactivity to homologous pp89 variant nonapeptides, the group 4 isolate N1 failed to do so. Finally, while immunization of mice with the nonapeptide YPHFMPTNL conferred significant protection against the laboratory strain K181 [correction of Kl81], no evidence of protection was observed for the group 2 and 4 variants G4 and N1, respectively. These observations raise the possibility that clinical isolates of HCMV may also differ in sequence from potential vaccine strains at immunodominant epitopes for CD8+ T cells thus reducing the efficacy of vaccination.
小鼠巨细胞病毒(MCMV;史密斯株)的即刻早期基因1(ie1)编码产物pp89的氨基酸序列YPHFMPTNL构成了一个与H-2Ld相关的免疫显性T细胞表位。对来自野生小鼠的MCMV分离株进行核苷酸测序发现,27个分离株中有19个的pp89氨基酸147 - 192之间存在变异,包括包含细胞毒性T淋巴细胞(CTL)表位的区域(氨基酸残基168 - 176)。定义了四组具有CTL表位天然变异序列的分离株:(1)YPHFMPPNL;(2)YPHFMPPSL;(3)YPHFIPPSL;和(4)YLDFMPPNL。其余分离株以及实验室菌株K181和温哥华株与史密斯株完全相同。多克隆pp89(史密斯株)特异性CTL仅微弱识别来自大多数变异组的感染MCMV的靶细胞。未检测到对来自第4组分离株N1感染的细胞的裂解。用变异MCMV分离株致敏的CTL对YPHFMPTNL肽包被靶标的交叉反应性识别分析表明,第2组和第3组分离株G4和K6分别诱导出表现出交叉反应的CTL,但第4组分离株N1没有。此外,虽然第2组和第3组分离株G4和K6能够诱导对同源pp89变异九肽具有反应性的CTL反应,但第4组分离株N1则不能。最后,用九肽YPHFMPTNL免疫小鼠可显著保护其免受实验室菌株K181的感染,但分别未观察到对第2组和第4组变异株G4和N1的保护证据。这些观察结果增加了人巨细胞病毒(HCMV)临床分离株在CD8 + T细胞免疫显性表位的序列上也可能与潜在疫苗株不同从而降低疫苗接种效果的可能性。